Navigation Links
PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
Date:8/1/2013

of anthrax infection that has completed two Phase 1 clinical trials.

Pre-Clinical Product Pipeline

In addition to four clinical-stage product candidates, the merged company will feature a robust pre-clinical pipeline driven by the proprietary I-STAR™ memory B-cell interrogation platform, which facilitates the discovery of human antibodies against novel targets.  Presently, Theraclone has an established collaboration with Pfizer for specific infectious disease and oncology indications for which they have received upfront payments and research funding and may receive development and commercialization milestones and royalties on product sales in the future based on successful advancement. Theraclone also has collaboration with Zenyaku Kogyo who licensed the rights of the flu antibody program for Japan.

Details of the Proposed Merger

The merger has been unanimously approved by both Boards of Directors and is subject to shareholder and regulatory approval, and other customary closing conditions.  Under the terms of the merger agreement, a wholly-owned subsidiary of PharmAthene will merge into Theraclone in an all-stock transaction.  PharmAthene will issue shares of PharmAthene common stock to Theraclone stockholders such that Theraclone stockholders will own 50% of the combined company.

Clifford J. Stocks, Chief Executive Officer of Theraclone, is expected to serve as President and Chief Executive Officer of the merged company.  Eric I. Richman will serve as a Director of the combined company's Board.  Leerink Swann and Healthios Capital Markets acted as financial advisors to PharmAthene and Theraclone, respectively.

Conference Call Information

PharmAthene management will host a conference call to discuss the proposed merger with Theraclone Sciences, Inc. The call is scheduled to begin at 9:00 a.m. E
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. PharmAthene Reports First Quarter 2013 Financial And Operational Results
2. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
3. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
4. PurThread Technologies Welcomes Life Sciences Veterans to CEO and Board Positions
5. Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack
6. Thomson Reuters Life Sciences Cortellis Competitive Intelligence Reaches Content Milestones
7. Sangamo BioSciences Reports Second Quarter 2013 Financial Results
8. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
9. MELA Sciences, Inc., A Leader In The Fight Against Melanoma, Hosts Symposium At 8th World Congress Of Melanoma
10. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
11. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PLEASANTON, Calif. , Nov. 26, 2014  Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in two upcoming investor conferences. On ... 26 th Annual Piper Jaffray Healthcare Conference.  ... will provide an update on the company beginning at ...
(Date:11/26/2014)... -- Cohen, Placitella & Roth, PC is investigating potential ... Pharmaceutical Corporation ("Nymox" or "Company") (NASDAQ: ... 2011 through November 2, 2014 ("Class Period").  The ... officers and directors publically disseminated materially false and/or ... 20(a) of the Securities Exchange Act of 1934 ...
(Date:11/26/2014)... VIEJO, Calif. , Nov. 26, 2014 /PRNewswire/ ... announced that the U.S. Food and Drug Administration ... its New Drug Application (NDA) for AVP-825. AVP-825 ... low-dose sumatriptan powder delivered intranasally utilizing a novel ... the Complete Response letter, and consistent with the ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4
... Federal, state and local dignitaries ushered in a ... with the dedication of a laboratory complex designed to ... The complex, housing 78 labs and other facilities, ... combining scientists from different fields and allowing them to ...
... Md., Oct 21, 2011 /PRNewswire-iReach/ -- ... accreditation for their Maryland Campus from the Accrediting Bureau ... meeting. ABHES is recognized by the United ... postsecondary institutions in the United States offering predominantly allied ...
Cached Medicine Technology:MUSC Dedicates New Bioengineering and Drug Discovery Hubs 2Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education 2
(Date:11/27/2014)... According to a recent report by iData Research ... the surgical robotics market may find significant ... field dominated by Intuitive. These companies are expected to ... by 2020. , “The MIS robotic device market ... President of iData. “System sales for the da Vinci ...
(Date:11/27/2014)... November 27, 2014 In a ... allot to sleep has lessened, and due to ... the quality of sleep has eroded. According to ... on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This ... index by an incalculable amount, leading not only ...
(Date:11/27/2014)... "As a nurse I see patients every ... incontinence," said an inventor from Whiting, N.J. "I put ... to prevent leakage and keep them dry and comfortable." ... This prevents stains on pants, skirts and bottoms, which ... that the individual has time to get to the ...
(Date:11/27/2014)... babies and young children don,t need medicines if they ... says. Over-the-counter (OTC) cold and cough medicine should ... they could cause serious and potentially deadly side effects, ... colds a year, but children get them more often. ... give them pain relievers, decongestants and other medicines, but ...
(Date:11/27/2014)... In order to enable people to adapt to the ... way to avoid touching a toilet seat and/or lid while ... of the patent-pending Toilet Tamer, a device that enables a ... in a more sanitary manner. It avoids direct contact with ... promotes good hygiene and peace of mind. The portable device ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
... piece of hearty news for cardiac patients who still would ... takes two to tango! And doctors have news that will ... shown that cardiac patients who were assigned waltz classes randomly ... than those cardiac patients assigned to cardiac rehabilitation that chiefly ...
... population based study conducted in Sweden points out that those ... as a result of allergy// to a substance called gluten ... times more prone to developing Type I Diabetes mellitus ... often before the age of twenty. ,Lead author ...
... of Duke University Medical Center, Magnetic Resonance Imaging (MRI) can ... early in patients with the immune system disorder sarcoidosis, who ... ,By using MRI to discover minute areas of heart ... take action to prevent sudden cardiac death, which is a ...
... influential tribal council in the northeastern state of Meghalaya ... rewards for doubling its population to two// million, its ... Council (KHADC), a constitutional body to protect and preserve ... state's Khasi and the Jaintia tribes could become extinct ...
... Researchers from Duke Medical Center have found that pregnant ... death and other medical complications compared to normal// pregnant ... of its kind, was conducted nationwide covering more than ... with systemic lupus should be considered a high-risk population ...
... Talkatora drew thousands of people on Saturday. The three day ... and its// complications. It has been estimated that nearly two ... and therefore a huge attendance was expected on Sunday. ... which in addition to diabetes also focused on various health ...
Cached Medicine News:Health News:From the frying pan into the fire: Celiac disease and diabetes 2Health News:MRI Detects Early Heart Damages In Patients 2Health News:MRI Detects Early Heart Damages In Patients 3Health News:Cash Rewards for Meghalaya Tribes to Encourage Baby Boom 2Health News:Pregnant Women With Lupus Are At Greater Risk 2Health News:Pregnant Women With Lupus Are At Greater Risk 3
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... easy on delicate urethral tissues. ... hydrophilic coating provide nearly friction-free ... It's easy to maintain sterility. ... with its own sterile water, ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products: